Zenas BioPharma, Inc. (ZBIO) Stock Overview
Explore Zenas BioPharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Zenas BioPharma, Inc. (ZBIO)
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
-3.30
EPS (TTM)
$-8.99
ROE
-1.90%
ZBIO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Zenas BioPharma, Inc. (NASDAQ: ZBIO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Zenas BioPharma, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ZBIO on the NASDAQ shows an RSI of 48.37, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $40.92 for the NASDAQ listing.
Key metrics behind Zenas BioPharma, Inc.'s NASDAQ-traded stock include a P/E ratio of -3.30 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZBIO on the NASDAQ.